HURON — Nearly everyone knows someone whose life has been touched by cancer at some point, and next to skin cancer, breast cancer is the most prevalent among females in the U.S.
To help in the fight to combat breast cancer, during October, which is breast cancer awareness month, Prostrollo General Motor and the Huron Regional Medical Center Foundation are once again partnering for the 5th annual “1 Mile Walk for Breast Cancer,” which will take place this Friday, Oct. 15, from 11 a.m. to 1 p.m. at Prostrollo’s and the adjacent walking path around Ravine Lake.
Shantel Tschetter, one of the organizers of this year’s event, said pre-registrations are running about normal to previous years, although last year’s numbers were down, due in part to the pandemic and a shot of winter weather that had snow and ice over portions of the walking path.
Indoors at Prostrollo’s, there will be drawings for door prizes from those who register for the event, goody bags and the all-important photo booth.
“The photo booth is important to the fundraising effort,” Tschetter noted, “because for every photo that is posted on Instragram with the hashtag #wedrivefor, Chevrolet will make a financial donation.”
Tschetter said all funds raised are directed toward the HRMC Foundation to aid the purchase of equipment specifically geared toward breast cancer diagnois.
“Some of the funds we have raised from past walks went to help pay for the new 3-D mammography unit that HRMC has just put in,” she added.
An estimated 1 in 8 women will diagnosed with breast cancer in her lifetime, so breast cancer screenings are a vital step in prevention via early diagnosis.
The American Cancer Society recommends the following for women at average risk for breast cancer:
• Women ages 40 to 44 should have the choice to start yearly breast cancer screening with a mammogram (x-ray of the breast) if they wish to do so.
• Women age 45 to 54 should get a mammogram every year.
• Women 55 and older can switch to a mammogram every 2 years, or can continue yearly screening.
Screening should continue as long as a woman is in good health and is expected to live at least 10 more years.